200 related articles for article (PubMed ID: 26157576)
1. The regulation of osteoclast differentiation by Wnt signals.
Kobayashi Y; Uehara S; Koide M; Takahashi N
Bonekey Rep; 2015; 4():713. PubMed ID: 26157576
[TBL] [Abstract][Full Text] [Related]
2. [Regulation of osteoclast differentiation by Wnt signals].
Kobayashi Y
Clin Calcium; 2013 Jun; 23(6):831-8. PubMed ID: 23719495
[TBL] [Abstract][Full Text] [Related]
3. Regulation of bone metabolism by Wnt signals.
Kobayashi Y; Uehara S; Udagawa N; Takahashi N
J Biochem; 2016 Apr; 159(4):387-92. PubMed ID: 26711238
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling and osteoblastogenesis.
Bodine PV; Komm BS
Rev Endocr Metab Disord; 2006 Jun; 7(1-2):33-9. PubMed ID: 16960757
[TBL] [Abstract][Full Text] [Related]
5. [Regulations of osteoclast formation and function by Wnt signals.].
Kobayashi Y; Uehara S; Koide M
Clin Calcium; 2019; 29(3):309-315. PubMed ID: 30814375
[TBL] [Abstract][Full Text] [Related]
6. The role of the Wnt signaling pathway in osteoblast commitment and differentiation.
Yavropoulou MP; Yovos JG
Hormones (Athens); 2007; 6(4):279-94. PubMed ID: 18055419
[TBL] [Abstract][Full Text] [Related]
7. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.
Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G
Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165
[TBL] [Abstract][Full Text] [Related]
8. Positive and Negative Regulators of Sclerostin Expression.
Iwamoto R; Koide M; Udagawa N; Kobayashi Y
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563281
[TBL] [Abstract][Full Text] [Related]
9. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
[TBL] [Abstract][Full Text] [Related]
10. Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation.
Glass DA; Karsenty G
Ann N Y Acad Sci; 2006 Apr; 1068():117-30. PubMed ID: 16831912
[TBL] [Abstract][Full Text] [Related]
11. Regulation of osteoclast function via Rho-Pkn3-c-Src pathways.
Uehara S; Udagawa N; Kobayashi Y
J Oral Biosci; 2019 Sep; 61(3):135-140. PubMed ID: 31400545
[TBL] [Abstract][Full Text] [Related]
12. The Anti-Osteoanabolic Function of Sclerostin Is Blunted in Mice Carrying a High Bone Mass Mutation of Lrp5.
Yorgan TA; Peters S; Jeschke A; Benisch P; Jakob F; Amling M; Schinke T
J Bone Miner Res; 2015 Jul; 30(7):1175-83. PubMed ID: 25640331
[TBL] [Abstract][Full Text] [Related]
13. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
[TBL] [Abstract][Full Text] [Related]
14. Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a.
Kobayashi Y; Thirukonda GJ; Nakamura Y; Koide M; Yamashita T; Uehara S; Kato H; Udagawa N; Takahashi N
Biochem Biophys Res Commun; 2015 Aug; 463(4):1278-83. PubMed ID: 26093292
[TBL] [Abstract][Full Text] [Related]
15. Wnt signaling in bone.
Kubota T; Michigami T; Ozono K
Clin Pediatr Endocrinol; 2010 Jul; 19(3):49-56. PubMed ID: 23926379
[TBL] [Abstract][Full Text] [Related]
16. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
[TBL] [Abstract][Full Text] [Related]
17. The Function of Wnt Ligands on Osteocyte and Bone Remodeling.
Du JH; Lin SX; Wu XL; Yang SM; Cao LY; Zheng A; Wu JN; Jiang XQ
J Dent Res; 2019 Jul; 98(8):930-938. PubMed ID: 31282847
[TBL] [Abstract][Full Text] [Related]
18. miR-409-5p negatively regulates Wnt/Beta catenin signaling pathway by targeting Lrp-8.
Prakash R; John AA; Singh D
J Cell Physiol; 2019 Dec; 234(12):23507-23517. PubMed ID: 31165485
[TBL] [Abstract][Full Text] [Related]
19. Regulatory mechanisms of sclerostin expression during bone remodeling.
Koide M; Kobayashi Y
J Bone Miner Metab; 2019 Jan; 37(1):9-17. PubMed ID: 30357564
[TBL] [Abstract][Full Text] [Related]
20. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
